Rockwell Medical Set to Unveil Q1 2023 Financial Results on May 15

Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI) is pleased to announce the release of its financial and operational results for the first quarter ended March 31, 2023.

On Monday, May 15, 2023, the Company will issue a press release at 6:00am ET, followed by a live conference call and webcast at 8:00am ET.

As a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, Rockwell Medical looks forward to providing its stakeholders with insight into its progress and outlook.

About Rockwell Medical

Rockwell Medical Inc. (NASDAQ: RMTI) is a healthcare company on a mission to provide superior service and products to dialysis clinics and their patients. We’re focused on developing, manufacturing, and distributing innovative hemodialysis products that make a positive impact on the lives of those suffering from end-stage kidney disease.

Our products are essential to those in need and we strive to deliver the best in reliability and customer service. As the second largest supplier of acid and bicarbonate concentrates in the U.S., we have the vision of becoming the leading global supplier of hemodialysis concentrates. We are committed to providing long-term growth strategies to ensure exceptional value to the healthcare system.

Leave a Comment